Bashir Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bashir Ahmad has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Yaser Gamallat
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
2 shared publications Yazeed Jamalat
College of Basic Medical Sciences, Dalian Medical University, Dalian City, People’s Republic of China
2 shared publicationsAbdo Meyiah
Department of Biotechnology, Dalian Medical University, Dalian, Liaoning, 116044, China
1 shared publicationAbdullah Shopit
Department of Pharmacology, Dalian Medical University, Dalian, Liaoning, 116044, China
1 shared publication- Ghulam Nabi
School of Food and Biological Engineering Jiangsu University Zhenjiang China
1 shared publication Hailong Li
Department of Pharmacology, Dalian Medical University, Dalian, Liaoning, 116044, China
1 shared publication
Latest Publications
- Open Access
- 1 March 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 2287-2297
Natural gypenosides: targeting cancer through different molecular pathways
The second foremost cause of mortality around the word is cancer. Conventional therapies, such as radiation, surgery, and chemotherapy have limited accessibility owing to secondary resistance. Therefore, convenient, safe, and nonresistant drugs are urgently needed. Plant-derived natural products have attracted considerable interest owing to their high efficacy, low toxicity, and convenience. Gypenosides (Gyp) inhibit invasion, migration, metastasis, and proliferation and induce apoptosis in different cancers, including oral, lung, colorectal, hepatocellular, and leukemic cancers through different molecular pathways. This review summarizes Gyp studies on cancer to serve as a reference for further research and clinical trials.
- 1 March 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 2287-2297
Open AccessNatural gypenosides: targeting cancer through different molecular pathways
The second foremost cause of mortality around the word is cancer. Conventional therapies, such as radiation, surgery, and chemotherapy have limited accessibility owing to secondary resistance. Therefore, convenient, safe, and nonresistant drugs are urgently needed. Plant-derived natural products have attracted considerable interest owing to their high efficacy, low toxicity, and convenience. Gypenosides (Gyp) inhibit invasion, migration, metastasis, and proliferation and induce apoptosis in different cancers, including oral, lung, colorectal, hepatocellular, and leukemic cancers through different molecular pathways. This review summarizes Gyp studies on cancer to serve as a reference for further research and clinical trials.
- 1 November 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 506 (3) , 611-618
Phosphocreatine attenuates endoplasmic reticulum stress-mediated hepatocellular apoptosis ameliorates insulin resistance in diabetes model
- 1 November 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 506 (3) , 611-618
Phosphocreatine attenuates endoplasmic reticulum stress-mediated hepatocellular apoptosis ameliorates insulin resistance in diabetes model